Faculty & Staff
Contact
-
Email
ravikanthnanduri.bt.ls@msruas.ac.in
- Websites
Dr. Ravikanth Nanduri
Assistant Professor
-
School/College
Faculty of Life and Allied Health Sciences
-
Department
Department of Biotechnology
Dr. Ravikanth Nanduri is a biomedical scientist with over 15 years of research experience in epigenetics, molecular biology, and immunology. His research investigates the transcriptional and epigenetic mechanisms underlying various disease physiologies, including cardiometabolic and infectious diseases, while integrating multi-omics and in-silico drug discovery approaches.
Before joining RUAS in 2025, Dr. Nanduri worked at the National Cancer Institute (NIH, USA) and the University of Texas Southwestern Medical Center (UTSW, USA), where he studied chromatin dynamics, macrophage polarization, and viral pathogenesis. His long-term research goal is to identify molecular signatures that link viral infections to accelerated atherosclerosis and sudden cardiac events.
Dr. Nanduri has authored over 30 peer-reviewed publications in leading international journals, including Nature Communications, Autophagy, Blood Advances, Journal of Biological Chemistry, and Cell and Molecular Life Sciences. His research has received more than 1,200 citations (Scopus H-index: 17; total impact factor: 167).
Qualifications
- PhD
Ph.D. in Molecular Biology and Immunology, CSIR–Institute of Microbial Technology, Chandigarh, India, 2016
- PG Programme
M.Sc. in Biotechnology, Andhra University, Visakhapatnam, 2009
- UG Programme
B.Sc. in Biotechnology, Biochemistry, and Microbiology, B. V. Raju College, Bhimavaram, Andhra Pradesh, affiliated to Andhra University, Visakhapatnam, India , 2007
Experience
Total Years of Experience
8 Years 6 Months
Academic Experience
8 years 6 months
- Assistant Professor, Department of Biotechnology, Faculty of Life and Allied Health Sciences, M. S. Ramaiah University of Applied Sciences, Bengaluru, India (2025–Present)
- Associate Professor, Department of Life Sciences, B. V. Raju College (Autonomous), Bhimavaram, Andhra Pradesh, India (2024–2025) Instructor, University of Texas Southwestern Medical Center, Dallas, USA (2023–2024)
- Postdoctoral Visiting Fellow, National Cancer Institute, National Institutes of Health (NIH), Bethesda, USA (2017–2023)
- Epigenetics and Gene Regulation
- Post-viral Infection–Associated Cardiometabolic Diseases
- Autophagy and Metabolic Reprogramming
- In-silico Drug Discovery
- Molecular Mechanism of Diseases
- Young Investigator Award, American Diabetes Association Scientific Sessions (2021)
- DST–SERB International Travel Support (ITS), Department of Science and Technology, Government of India (2015)
- G. P. Talwar Travel Fellowship, Indian Immunological Society (2015)
- BD–TCS Award for Excellence in Flow Cytometry, Becton Dickinson–TCS Foundation (2012)
- Qualified CSIR–UGC–NET (UGC Fellowship) and GATE-2009, Government of India (2009)
Selected Publications:
- Kombe Kombe AJ, Fotoohabadi L, Gerasimova Y, Nanduri R, Lama Tamang P, Kandala M, Kelesidis T. The Role of Inflammation in the Pathogenesis of Viral Respiratory Infections. Microorganisms. 2024; 12(12):2526.
- Kombe Kombe AJ, Fotoohabadi L, Nanduri R, Gerasimova Y, Daskou M, Gain C, Sharma E, Wong M, Kelesidis T. The Role of the Nrf2 Pathway in Airway Tissue Damage Due to Viral Respiratory Infections. Int J Mol Sci. 2024; 25:7042.
- Daskou M, Fotooh Abadi L, Gain C, Wong M, Sharma E, Kombe Kombe AJ, Nanduri R, Kelesidis T. The Role of the NRF2 Pathway in the Pathogenesis of Viral Respiratory Infections. Pathogens. 2023; 13(1):39.
- Kumar S, Arora R, Gupta S, Ahuja N, Bhagyaraj E, Nanduri R, et al. Nuclear Receptor Rev-erbα Role in Fine-Tuning Erythropoietin Gene Expression. Blood Advances. 2024; 8(14):3705–3717.
- He B, Furusawa T, Nanduri R, Ishikawa M, Zhang P, Amendt B, Yamada Y, Bustin M. Epigenetic Regulation of Ameloblast Differentiation by HMGN Proteins. J Dent Res. 2024; 103(1):51–61.
- Nanduri R, Furusawa T, Lobanov A, He B, Xie C, Gavrilova O, Gonzalez FJ, Bustin M. Epigenetic Regulation of White Adipose Tissue Plasticity and Energy Metabolism by Nucleosome Binding HMGN Proteins. Nat Commun. 2022; 13:7303. (Co-corresponding author)
- He B, Zhu I, Postnikov Y, Furusawa T, Jenkins L, Nanduri R, Bustin M, Landsman D. Multiple Epigenetic Factors Co-localize with HMGN Proteins in A-compartment Chromatin. Epigenetics Chromatin. 2022; 15(1):23.
- Tiwari D, Ahuja N, Kumar S, Nanduri R, Gupta P, et al. Nuclear Receptor Nr1d1 Alleviates Asthma by Abating GATA3 Gene Expression and Th2 Cell Differentiation. Cell Mol Life Sci. 2022; 79:308.
- Nanduri R. Epigenetic Regulators of White Adipocyte Browning. Epigenomes. 2021; 5(1):3. (Invited Review)
- Kumar S, Nanduri R, Bhagyaraj E, et al. Vitamin D3–VDR–PTPN6 Axis Mediated Autophagy Contributes to the Inhibition of Macrophage Foam Cell Formation. Autophagy. 2021; 17(9):2273–2289. (Co-first author)
- Nanduri R, Mahajan S, Bhagyaraj E, Sethi K, Kalra R, Chandra V, Gupta P. The Active Form of Vitamin D Transcriptionally Represses Smad7 Signaling and Activates ERK to Inhibit Inflammatory T Helper Cell Differentiation and Suppress Experimental Autoimmune Encephalomyelitis. J Biol Chem. 2015; 290(19):12222–36.
- Nanduri R, Bhutani I, Somavarapu AK, Mahajan S, Parkesh R, Gupta P. ONRLDB—Manually Curated Database of Experimentally Validated Ligands for Orphan Nuclear Receptors: Insights into New Drug Discovery. Database (Oxford). 2015; 2015:bav112.
- Dkhar HK, Nanduri R, Mahajan S, Dave S, Saini A, Somavarapu AK, Arora A, Parkesh R, Thakur KG, Mayilraj S, Gupta P. Mycobacterium tuberculosis Keto-mycolic Acid and Macrophage Nuclear Receptor TR4 Modulate Foamy Biogenesis in Granulomas. J Immunol. 2014; 193(1):295–305.
- Dave S, Nanduri R, Dkhar HK, Bhagyaraj E, Rao A, Gupta P. Nuclear MEK1 Sequesters PPARγ and Bisects MEK1/ERK Signaling: A Non-canonical Pathway of Retinoic Acid Inhibition of Adipocyte Differentiation. PLoS One. 2014; 9(6):e100862.
- Sonkusre P, Nanduri R, Gupta P, Singh S, Cemotra S. Improved Extraction of Intracellular Biogenic Selenium Nanoparticles and Their Specificity for Cancer Chemoprevention. J Nanomed Nanotechnol. 2014; 5(2):1–8.
- Life Member, Indian Immunological Society
- Life Member, Society of Biological Chemists (India)
- Life Member, Society for Biotechnologists (India)
- Editorial Board Member, Frontiers in Immunology
- Academic Editor, PLOS ONE and Vaccines (MDPI) (2021–2022)
- Peer Reviewer for Theranostics, Scientific Reports, BMC Genomics, BMC Immunology, Frontiers in Genetics, Journal of Inflammation Research, and others (73 verified reviews)
ADDRESS
